Back to search
Diabetic Nephropathy Type 2
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Diabetic Nephropathy Type 2 trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Diabetic Nephropathy Type 2 trials you may qualify forThe overarching goal of this study is to understand facilitators and barriers to self-care, develop and refine a culturally tailored intervention to improve cli…
This study is researching experimental drugs called ALN-ANG3 and evinacumab (called "study drugs"). The study is focused on participants who have diabetic kidne…
This study will evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single ascending doses (SAD) and multiple ascending doses (MA…
A phase 2a trial randomized, double-blind, placebo-controlled, parallel group trial to determine whether NMN administration improves DKD, as indicated by a sign…
PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among…
Diabetes mellitus
Background: \- An ongoing study is looking at American Indians who have kidney problems caused by type 2 diabetes. Kidney disease due to type 2 diabetes is a m…
The Family Investigation of Nephropathy and Diabetes (FIND) is a multicenter study designed to identify genetic determinants of diabetic kidney disease. FIND wi…
Background: \- Family and twin studies have suggested that genetic factors influence approximately 50 percent of a person's susceptibility to type 2 diabetes.…